scholarly journals Treatment Patterns, Resource Utilization And Costs In Muscular Dystrophy Patients: Analysis Using Administrative Claims Data

2015 ◽  
Vol 18 (7) ◽  
pp. A764-A765
Author(s):  
M Stott-Miller ◽  
A Vlahiotis ◽  
LA Palmer
Keyword(s):  
Muscular Dystrophy ◽  
Resource Utilization ◽  
Claims Data ◽  
Treatment Patterns ◽  
Administrative Claims ◽  
Administrative Claims Data

Evaluate algorithms for identifying treatment patterns for patients with metastatic colorectal cancer using administrative claims data.

2014 ◽  
Vol 32 (30_suppl) ◽  
pp. 299-299
Author(s):  
Yue Zhong ◽  
Rajesh Kamalakar ◽  
Carl V Asche ◽  
Sibyl Anderson ◽  
Brian S. Seal
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Claims Data ◽  
Distant Metastases ◽  
Treatment Patterns ◽  
New Drugs ◽  
Administrative Claims ◽  
Biologic Drugs ◽  
Administrative Claims Data ◽  
Treatment Regimens

299 Background: Administrative claims data are widely used to identify treatment patterns. However, as new drugs are brought to clinical practice, treatment regimens become more complicated for cancer patients receiving both chemotherapy and biologic agents. We evaluated the influence of using different treatment length algorithms on identification of treatment patterns for patients with metastatic colorectal cancer (mCRC). Methods: We identified patients aged 18 or older with at least one primary CRC diagnosis between 01/01/2008 and 03/31/2012 in the MarketScan databases. mCRC patients were included if claims indicated the presence of distant metastases (ICD-9-CM codes: 196.x, 197.0 to 197.4, 197.6 to 197.8, 198.x, and 199.0). All treatment claims were extracted and patients were followed for more than 6 months, until end of enrollment or study end date (03/01/2013). We identified all chemotherapy and/or biologic drugs given to a patient during 30, 60, or 90 days after initiation of treatment and compared differences in type and number of treatment lines (TLs). Results: A total of 2,046 mCRC patients received at least one TL. Using a 30-day cutoff period, 30% patients received 1 TL; 30% received 2 TLs; and 40% received ≥3 TLs. Results changed after using a 60-day cutoff period: 39% patients with 1 TL, 33% with 2 TLs, and 28% with ≥3 TLs. If using 90 days as a cutoff period, 44% received 1 TL; 35% received 2 TLs; and 22% received ≥3 TLs. For all cutoff periods, the most common first TL prescribed were FOLFOX +/- bevacizumab and 5-FU/LV. For patients receiving a second TL, FOLFOX was most frequently prescribed if using a 30-day or 60-day cutoff, while FOLFIRI/bevacizumab had a higher prescription rate with a 90-day cutoff. Regimens varied in third and fourth-line therapy using different cutoff periods and FOLFIRI +/- bevacizumab was more frequently used than other regimens. Conclusions: The cutoff period did not significantly influence treatment regimens detected for first and second TL. Using a 30-day cutoff period resulted in 30% patients with one TL and 40% with three or more TLs, while with a 90-day cutoff, 44% patients received one TL and only 22% received three or more TLs.

scholarly journals Demographics, Treatment Patterns, and Morbidity in Patients with Exercise-Induced Bronchoconstriction: An Administrative Claims Data Analysis

2021 ◽  
Vol Volume 14 ◽  
pp. 1485-1495
Author(s):  
Miguel J Lanz ◽  
Ileen A Gilbert ◽  
Hitesh N Gandhi ◽  
Nadia Goshi ◽  
Joseph P Tkacz ◽  
...  
Keyword(s):  
Data Analysis ◽  
Claims Data ◽  
Treatment Patterns ◽  
Administrative Claims ◽  
Administrative Claims Data ◽  
Exercise Induced ◽  
Claims Data Analysis

scholarly journals Characterization of bariatric surgery and outcomes using administrative claims data in the research network of a nationwide commercial health plan

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Qinli Ma ◽  
Michael Mack ◽  
Sonali Shambhu ◽  
Kathleen McTigue ◽  
Kevin Haynes
Keyword(s):  
Bariatric Surgery ◽  
Health Systems ◽  
Comparative Effectiveness ◽  
Claims Data ◽  
Research Network ◽  
Hospital Death ◽  
Administrative Claims ◽  
Administrative Claims Data ◽  
Abdominal Operations

Abstract Background The supplementation of electronic health records data with administrative claims data may be used to capture outcome events more comprehensively in longitudinal observational studies. This study investigated the utility of administrative claims data to identify outcomes across health systems using a comparative effectiveness study of different types of bariatric surgery as a model. Methods This observational cohort study identified patients who had bariatric surgery between 2007 and 2015 within the HealthCore Anthem Research Network (HCARN) database in the National Patient-Centered Clinical Research Network (PCORnet) common data model. Patients whose procedures were performed in a member facility affiliated with PCORnet Clinical Research Networks (CRNs) were selected. The outcomes included a 30-day composite adverse event (including venous thromboembolism, percutaneous/operative intervention, failure to discharge and death), and all-cause hospitalization, abdominal operation or intervention, and in-hospital death up to 5 years after the procedure. Outcomes were classified as occurring within or outside PCORnet CRN health systems using facility identifiers. Results We identified 4899 patients who had bariatric surgery in one of the PCORnet CRN health systems. For 30-day composite adverse event, the inclusion of HCARN multi-site claims data marginally increased the incidence rate based only on HCARN single-site claims data for PCORnet CRNs from 3.9 to 4.2%. During the 5-year follow-up period, 56.8% of all-cause hospitalizations, 31.2% abdominal operations or interventions, and 32.3% of in-hospital deaths occurred outside PCORnet CRNs. Incidence rates (events per 100 patient-years) were significantly lower when based on claims from a single PCORnet CRN only compared to using claims from all health systems in the HCARN: all-cause hospitalization, 11.0 (95% Confidence Internal [CI]: 10.4, 11.6) to 25.3 (95% CI: 24.4, 26.3); abdominal operations or interventions, 4.2 (95% CI: 3.9, 4.6) to 6.1 (95% CI: 5.7, 6.6); in-hospital death, 0.2 (95% CI: 0.11, 0.27) to 0.3 (95% CI: 0.19, 0.38). Conclusions Short-term inclusion of multi-site claims data only marginally increased the incidence rate computed from single-site claims data alone. Longer-term follow up captured a notable number of events outside of PCORnet CRNs. The findings suggest that supplementing claims data improves the outcome ascertainment in longitudinal observational comparative effectiveness studies.

scholarly journals Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data

2020 ◽  
Vol 9 (4) ◽  
Author(s):  
Sanket S. Dhruva ◽  
Craig S. Parzynski ◽  
Ginger M. Gamble ◽  
Jeptha P. Curtis ◽  
Nihar R. Desai ◽  
...  
Keyword(s):  
Adverse Events ◽  
Stent Placement ◽  
Claims Data ◽  
Coronary Stent ◽  
Administrative Claims ◽  
Administrative Claims Data

Validation of diabetes case definitions using administrative claims data

2011 ◽  
Vol 28 (4) ◽  
pp. 424-427 ◽  
Author(s):  
S. Amed ◽  
S. E. Vanderloo ◽  
D. Metzger ◽  
J.-P. Collet ◽  
K. Reimer ◽  
...  
Keyword(s):  
Claims Data ◽  
Administrative Claims ◽  
Case Definitions ◽  
Administrative Claims Data ◽  
Diabetes Case
Sign in / Sign up

Export Citation Format

Share Document